Travaux scientifiques

Doç. Dr. Gupse Adalı

103 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD)

    Hepatology forum/Hepatology forum (Online), 2026

    DOI 10.14744/hf.2026.44190 PMID 42609490 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  2. Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the turkish population: A multicenter study

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2026

    DOI 10.1097/lvt.0000000000000863 PMID 41974028 1 citation (Europe PMC) Source : ORCID

  3. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis

    Clinical Transplantation, 2026

    DOI 10.1111/ctr.70436 PMID 41493043 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  4. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia

    Hepatology International, 2026

    DOI 10.1007/s12072-026-11037-z PMID 41639358 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  5. Chanarin-Dorfman Syndrome: Two siblings with steatohepatitis, cirrhosis, and a novel mutation

    Hepatology Forum, 2026

    DOI 10.14744/hf.2024.0039 Texte intégral en libre accèsSource : ORCID

  6. Depressive Symptoms, Sleep Quality, and Anhedonia in Patients with Primary Biliary Cholangitis: A Cross-Sectional Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15207967 PMID 42941482 Texte intégral en libre accèsSource : ORCID

  7. Familial Low-Phospholipid-Associated Cholelithiasis Syndrome Presenting with Recurrent Intrahepatic Stones After Cholecystectomy with a Heterozygous ABCB4 Variant

    Turkish Journal of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.26254 PMID 42504617 Texte intégral en libre accèsSource : ORCID

  8. Complete Immunosuppression Withdrawal After Liver Transplantation: An International Multicenter Study

    Clinical Gastroenterology and Hepatology, 2026

    DOI 10.1016/j.cgh.2026.05.027 PMID 42263796 Texte intégral en libre accèsSource : ORCID

  9. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes

    Turkish Journal of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.25748 PMID 41942375 Texte intégral en libre accèsSource : ORCID

  10. Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure

    Hepatology International, 2026

    DOI 10.1007/s12072-025-10914-3 PMID 41137971 7 citations (Europe PMC) Source : ORCID

  11. High burden of depression, sleep disturbance, and anhedonia in primary biliary cholangitis independent of fibrosis stage and prognostic scores

    Journal of Hepatology, 2026

    Source : ORCID

  12. Long-term outcomes of patients with complete immunosuppression withdrawal after liver transplantation: a multicentre, worldwide study

    Journal of Hepatology, 2026

    Source : ORCID

  13. A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper

    Hepatology International, 2026

    DOI 10.1007/s12072-026-11116-1 PMID 42533257 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  14. CARACTERÍSTICAS CLÍNICAS Y PRONÓSTICO A LARGO PLAZO DE PACIENTES CON SUSPENSIÓN COMPLETA DEL TRATAMIENTO INMUNOSUPRESOR TRAS EL TRASPLANTE HEPÁTICO

    Gastroenterología y Hepatología, 2026

    DOI 10.1016/s0210-5705(26)00386-9 Source : OpenAlex

  15. Tu2050 DIABETES MELLITUS AND DISEASE SEVERITY AT PRESENTATION AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT FROM SAUDI ARABIA, EGYPT, AND TURKEY

    Gastroenterology, 2026

    DOI 10.1016/s0016-5085(26)04141-7 Source : OpenAlex

  16. Tu2050 DIABETES MELLITUS AND DISEASE SEVERITY AT PRESENTATION AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT FROM SAUDI ARABIA, EGYPT, AND TURKEY

    Gastrointestinal Endoscopy, 2026

    DOI 10.1016/s0016-5107(26)04072-1 Source : OpenAlex

  17. OS-091 Long-term outcomes of patients with complete immunosuppression withdrawal after liver transplantation: a multicentre, worldwide study

    Journal of Hepatology, 2026

    DOI 10.1016/s0168-8278(26)00401-0 Source : OpenAlex

  18. FRI-511-YI Sex-based inequities in liver transplant access associated with jaffe creatinine measurement bias: an analysis from the scientific registry of transplant recipients data

    Journal of Hepatology, 2026

    DOI 10.1016/s0168-8278(26)01205-5 Source : OpenAlex

  19. SAT-246 High burden of depression, sleep disturbance, and anhedonia in primary biliary cholangitis independent of fibrosis stage and prognostic scores

    Journal of Hepatology, 2026

    DOI 10.1016/s0168-8278(26)00980-3 Source : OpenAlex

  20. The Global ACLF Consensus : the ‘Istanbul Document’

    Hepatology International, 2026

    DOI 10.1007/s12072-026-11136-x PMID 42782569 Texte intégral en libre accèsSource : OpenAlex

  21. Leukocytoclastic vasculitis as a rare adverse effect of ustekinumab in a patient with Crohn’s disease

    Journal of Gastrointestinal and Liver Diseases, 2025

    DOI 10.15403/jgld-6036 PMID 40153823 Texte intégral en libre accèsSource : OpenAlex

  22. Splenic Artery Aneurysm Following Endoscopic Ultrasound Guided Fine-Needle Aspiration: A Rare Complication Presenting with Delayed Massive Gastrointestinal Bleeding

    Turkish Journal of Gastroenterology, 2025

    DOI 10.5152/tjg.2025.25457 PMID 41669924 Texte intégral en libre accèsSource : ORCID

  23. Virologic Response at 12 Months Predicts Lower Hepatocellular Carcinoma Risk in Genotype D Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14082618 PMID 40283448 Texte intégral en libre accèsSource : ORCID

  24. Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia

    Hepatology International, 2025

    DOI 10.1007/s12072-024-10773-4 PMID 39961976 83 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  25. Non-invasive tests fail to ensure therapeutic precision for resmetirom in MASLD

    Hepatology Forum, 2025

    DOI 10.14744/hf.2025.2025.0055 PMID 40686598 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  26. Temporal Trends and Regional Variations in Hepatocellular Carcinoma Etiology: A Multinational Study Across Asia

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7542712/v1 Texte intégral en libre accèsSource : ORCID

  27. FRI-221 APASL ACLF research consortium (AARC) liver failure score and first week(transplant window) defines the limits of medical management and time frame for liver transplant in acute on chronic liver failure patients

    Journal of Hepatology, 2025

    DOI 10.1016/s0168-8278(25)00601-4 Source : OpenAlex

  28. SAT-470 Impact of diabetes mellitus on mortality in alcohol-related acute-on-chronic liver failure: a study from the AARC database

    Journal of Hepatology, 2025

    DOI 10.1016/s0168-8278(25)00520-3 Source : OpenAlex

  29. THU-414 Rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-associated hepatocellular carcinoma: a comparative analysis of clinical features and outcomes

    Journal of Hepatology, 2025

    DOI 10.1016/s0168-8278(25)01401-1 Source : OpenAlex

  30. WED-101 Hepatocellular carcinoma in the MENA region differs in presentation and outcomes: an analysis of 2736 patients from Saudi Arabia, Oman, Egypt and Turkiye

    Journal of Hepatology, 2025

    DOI 10.1016/s0168-8278(25)01183-3 Source : OpenAlex

  31. P235 Impact of body mass index on survival outcomes in hepatocellular carcinoma patients treated with locoregional therapies in the MENA region

    Gut, 2025

    DOI 10.1136/gutjnl-2025-bsg.369 Source : OpenAlex

  32. Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e37990 PMID 39328534 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  33. The diagnostic performance of non-invasive fibrosis markers for predicting fibrosis in primary biliary cholangitis patients

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1594235 Texte intégral en libre accèsSource : OpenAlex

  34. AARC LIVER FAILURE SCORE BASED ON REGISTRY OF 10,994 PATIENTS IS A BETTER PROGNOSTIC MODEL FOR ACLF PATIENTS JUSTIFYING GLOBAL APPLICATION AND EXPANSION OF AARC DATABASE

    Hepatology, 2024

    Source : ORCID

  35. Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease: Metabolic Risk Factors are Key Drivers of Hepatocellular Carcinoma

    Ssrn, 2024

    DOI 10.2139/ssrn.4917812 Source : ORCID

  36. De novo malignancies after liver transplantation: multicenter study a preliminary report

    Liver Transplantation, 2024

    Source : ORCID

  37. Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

    Journal of Hepatology, 2024

    Source : ORCID

  38. Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices

    Journal of Clinical and Experimental Hepatology, 2024

    DOI 10.1016/j.jceh.2024.101347 PMID 38371606 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  39. Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

    Journal of Hepatology, 2024

    Source : ORCID

  40. THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

    Journal of Hepatology, 2024

    DOI 10.1016/s0168-8278(24)00761-x Source : OpenAlex

  41. THU-171 Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

    Journal of Hepatology, 2024

    DOI 10.1016/s0168-8278(24)01139-5 Source : OpenAlex

  42. Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease

    Journal of Hepatology, 2023

    DOI 10.1016/s0168-8278(23)00710-9 1 citation (OpenAlex) Source : ORCID

  43. Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study

    Hepatology Forum, 2023

    DOI 10.14744/hf.2023.2023.0032 PMID 37822311 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  44. Prediction of Prognosis Acute Pancreatitis with Inflammatory Markers and Patient Characteristics Compared to the Scoring System: Real-Life Data

    SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital, 2023

    DOI 10.14744/semb.2022.42966 PMID 37899813 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  45. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

    Hepatology Forum, 2023

    DOI 10.14744/hf.2023.2023.0011 PMID 37920782 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  46. The effect of clinicopathologic findings of hepatocellular carcinoma on posttransplant survival: a multcenter cohort from TASL liver transplantation special interest group

    Journal of Hepatology, 2022

    DOI 10.1016/s0168-8278(22)01877-3 Source : OpenAlex

  47. A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

    The Turkish Journal of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.21072 PMID 35550537 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  48. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment

    World Journal of Gastroenterology, 2022

    DOI 10.3748/wjg.v28.i6.665 PMID 35317422 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  49. Characteristics of patients with hepatocellular carcinoma: A multicenter study

    Hepatology forum/Hepatology forum (Online), 2022

    DOI 10.14744/hf.2022.2022.0028 PMID 36177097 14 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  50. Portal vein thrombosis risk factors in liver transplant candidates

    Hepatology Forum, 2022

    DOI 10.14744/hf.2022.2022.0005 PMID 36177096 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID